Frequently Asked Questions
The market is segmented based on Global Direct-to-Consumer (DTC) Genetic Testing Market, By Service (Diagnostic Screening, Prenatal, New-born Screening, Pre-Implantation Diagnosis and Relationship Testing), Test Type (Carrier Testing, Predictive Testing, Ancestry and Relationship Testing, Nutrigenomics Testing and Others), Technology (Targeted Analysis, Single Nucleotide Polymorphism (SNP) Chips and Whole Genome Sequencing (WGS)), Product Type (Ancestry, Health and Wellness and Entertainment), Business Model (Genome Data Bank Material Model, Individual Health Planning Model, Comprehensive Genome Tests Model, Medical Precision Tests Model and Restricted Trait Tests Model), End User (Laboratories, Blood Banks, Nursing Homes, Hospitals, Imaging Centres, Home Care, Cosmetics and Others), Sales Channel (Online Sales, OTC Sales and Doctor's Office)) - Industry Trends and Forecast to 2030.
.
The Global Direct To Consumer Dtc Genetic Testing Market size was valued at USD 1550.51 USD Million in 2022.
The Global Direct To Consumer Dtc Genetic Testing Market is projected to grow at a CAGR of 12.15% during the forecast period of 2023 to 2030.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..
